Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

Psoriatic arthritis (PsA) is a form of arthritis that affects about one-third of people with psoriasis ... covered with silvery-white scales, called plaques. Plaques may itch, burn, or hurt.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Oral, once-daily doses of VYN202 being evaluated in subjects with moderate-to-severe plaque psoriasisTop-line data from the 12-week double-blind ...

A real-world study in Spain finds faster improvements with induction therapy but highlights long-term drug survival ...

Plaque psoriasis is the most common ... Psoriasis and psoriatic arthritis are different diseases, but they are related. Some people may have both at the same time. Whether you're newly diagnosed ...

Super Bowl LIX champion Dallas Goedert of the Philadelphia Eagles shares his journey with plaque psoriasis. After 20 years of ...

psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR).

We describe 5 patients with moderate to severe chronic plaque psoriasis and 6 patients with psoriatic arthritis that was refractory to conventional systemic and/or topical antipsoriatic treatment ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...